• Latest Posts

Alzheimer’s drugs could result from immune brain cell discovery

Ultra-long protein fibrils could help with early Alzheimer’s diagnosis

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline 

6 new vaccines being developed for difficult-to-treat diseases

Alzamend pushing ahead with Alzheimer’s vaccine trial

€260M fund addresses dementia investment shortfall


Could changing mRNA provide a new target for Alzheimer’s disease?

Talking about Alzheimer’s disease: current drugs, clinical trials, and the pipeline

More News! 25 Mar 2019

Swedish Biotech’s Stock Severely Hit by Failure of Biogen’s Alzheimer’s Drug

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

Lifesciences and biotech in 2023